Novavax, Inc. (NVAX)
9.20
-0.02
(-0.27%)
USD |
NASDAQ |
Feb 20, 16:00
9.20
0.00 (0.00%)
After-Hours: 20:00
Novavax SG&A Expense (Quarterly) : 31.66M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.898B |
| Pfizer Inc. | 4.162B |
| Moderna, Inc. | 308.00M |
| Recursion Pharmaceuticals, Inc. | 41.63M |
| Plus Therapeutics, Inc. | 3.443M |